CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
interventional techniques, the severity of placental invasion, and various placental positions and suture techniquesprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06105034
NCT06105034N/ACompleted
CompareCT.gov

Placenta Accreta Spectrum Disorder Conservative Managment Versus Hysterectomy Prospective Analysis

Nourhan Elsadany·observational·Posted Oct 27, 2023·Updated Nov 7, 2023

In Brief

An observational study evaluating interventional techniques, the severity of placental invasion, and various placental positions and suture techniques for Placenta Accreta. Completed, enrolled 300 participants across 1 site.

Detailed Summary

The aim of this study is to identify risk factors associated with performing cesarean hysterectomy versus conservative management in patients with placenta accreta spectrum (PAS). Research question What are the risk factors associated with cesarean hysterectomy in patients with placenta accreta spectrum? Research hypothesis There are certain risk factors associated with cesarean hysterectomy in patients with Placenta accreta spectrum (PAS).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPlacenta Accreta
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedOct 27, 2023
Enrollment StartMar 1, 2022
Primary CompletionSep 1, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 2.7 years ago

Interventions

interventional techniques, the severity of placental invasion, and various placental positions and suture techniquesprocedure

Clinically, severe complications of PA include severe obstetric hemorrhage leading to disseminated intravascular coagulopathy (DIC), iatrogenic injury to the ureters, bladder, bowel, respiratory distress syndrome (RDS), acute transfusion reactions, electrolyte imbalance, and renal failure. In women with PA, the expected blood loss at delivery is 3000- 5000 mL, About 90% of patients require a blood transfusion with 40% requiring more than ten units of packed cell transfusion